Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hungarian National Systemic Amyloidosis Registry (AMYREG) - A Multi-Center, Longitudinal, Observational Survey of Patients With Systemic Amyloidosis

NCT07689331 is registered in ClinicalTrials.gov with Semmelweis University as lead sponsor.

NCT NCT07689331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07689331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hungarian National Systemic Amyloidosis Registry (AMYREG) - A Multi-Center, Longitudinal, Observational Survey of Patients With Systemic Amyloidosis
Lead sponsor
Semmelweis University
Phase
Observational
Overall status
Recruiting
Start date
March 8, 2026
Completion date
May 31, 2028
Enrollment
300 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

al amyloidosis, amyloid cardiomyopathy, attr amyloidosis, systemic amyloidosis